Literature DB >> 29429825

Emerging roles of microRNAs in cancer.

Ivan Vannini1, Francesca Fanini1, Muller Fabbri2.   

Abstract

MicroRNAs (miRNAs) have emerged as important regulators of human carcinogenesis by affecting the expression of key oncogenes and tumor suppressor genes. MiRNAs elicit their function through post-transcriptional regulation of the mRNA translation into protein as well as functioning as ligands for proteic receptors called miRceptors. Our understanding of the role of miRNAs in cancer biology has enormously improved in the last few years, providing the rationale for new therapeutics. Here we discuss the most recent findings on the role of miRNAs in modulating cancer biology with a specific focus on their role as modulators of the biology of the tumor microenvironment both as cargo of extracellular vesicles and as extra-vesicular miRNAs.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29429825      PMCID: PMC5986298          DOI: 10.1016/j.gde.2018.01.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  34 in total

1.  MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.

Authors:  M Janaki Ramaiah; A Lavanya; Mohsen Honarpisheh; Mojtaba Zarea; Utpal Bhadra; Manika Pal Bhadra
Journal:  Gene       Date:  2014-09-26       Impact factor: 3.688

2.  Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.

Authors:  Katrien Van Roosbroeck; Francesca Fanini; Tetsuro Setoyama; Cristina Ivan; Cristian Rodriguez-Aguayo; Enrique Fuentes-Mattei; Lianchun Xiao; Ivan Vannini; Roxana S Redis; Lucilla D'Abundo; Xinna Zhang; Milena S Nicoloso; Simona Rossi; Vianey Gonzalez-Villasana; Rajesha Rupaimoole; Manuela Ferracin; Fortunato Morabito; Antonino Neri; Peter P Ruvolo; Vivian R Ruvolo; Chad V Pecot; Dino Amadori; Lynne Abruzzo; Steliana Calin; Xuemei Wang; M James You; Alessandra Ferrajoli; Robert Orlowski; William Plunkett; Tara M Lichtenberg; Ramana V Davuluri; Ioana Berindan-Neagoe; Massimo Negrini; Ignacio I Wistuba; Hagop M Kantarjian; Anil K Sood; Gabriel Lopez-Berestein; Michael J Keating; Muller Fabbri; George A Calin
Journal:  Clin Cancer Res       Date:  2016-11-30       Impact factor: 12.531

3.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

4.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.

Authors:  Jason D Arroyo; John R Chevillet; Evan M Kroh; Ingrid K Ruf; Colin C Pritchard; Donald F Gibson; Patrick S Mitchell; Christopher F Bennett; Era L Pogosova-Agadjanyan; Derek L Stirewalt; Jonathan F Tait; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

Review 5.  The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism?

Authors:  Patrick J Babin; Geoffrey F Gibbons
Journal:  Prog Lipid Res       Date:  2008-11-21       Impact factor: 16.195

6.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

7.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

Review 8.  Discovery of small molecule cancer drugs: successes, challenges and opportunities.

Authors:  Swen Hoelder; Paul A Clarke; Paul Workman
Journal:  Mol Oncol       Date:  2012-03-03       Impact factor: 6.603

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

Review 10.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

View more
  58 in total

1.  Genipin inhibits the scleral expression of miR-29 and MMP2 and promotes COL1A1 expression in myopic eyes of guinea pigs.

Authors:  Min Wang; Zhi-Kuan Yang; Hong Liu; Rui-Qin Li; Yu Liu; Wen-Jun Zhong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-03       Impact factor: 3.117

2.  MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway.

Authors:  Zhongbo Han; Chao Zhang; Qingfeng Wang; Liang Li; Meng Wang; Xi Li; Chunxia Yang
Journal:  Clin Med Insights Oncol       Date:  2021-05-05

3.  MicroRNA-199-3p targets Sp1 transcription factor to regulate proliferation and epithelial to mesenchymal transition of human lung cancer cells.

Authors:  Jiajia Fu; Tong Li; Xiaozhen Jiang; Bin Xia; Lijuan Hu
Journal:  3 Biotech       Date:  2021-06-22       Impact factor: 2.893

4.  MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2.

Authors:  Xiangdong Tong; Peng Su; Haitao Yang; Fusheng Chi; Lin Shen; Xiao Feng; Hongqian Jiang; Xiuchun Zhang; Zhenyuan Wang
Journal:  Exp Ther Med       Date:  2018-10-03       Impact factor: 2.751

Review 5.  MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol.

Authors:  Jean-Jacques Michaille; Victoria Piurowski; Brooke Rigot; Hesham Kelani; Emily C Fortman; Esmerina Tili
Journal:  Medicines (Basel)       Date:  2018-07-09

6.  miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs).

Authors:  Adele Vivacqua; Anna Sebastiani; Anna Maria Miglietta; Damiano Cosimo Rigiracciolo; Francesca Cirillo; Giulia Raffaella Galli; Marianna Talia; Maria Francesca Santolla; Rosamaria Lappano; Francesca Giordano; Maria Luisa Panno; Marcello Maggiolini
Journal:  Cells       Date:  2018-11-09       Impact factor: 6.600

7.  Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma.

Authors:  Meisi Huo; Kangkang Yu; Yahui Zheng; Lu Liu; Hao Zhao; Xiaoqi Li; Chong Huang; Jubo Zhang
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

Review 8.  Circular RNAs as novel potential biomarkers for pancreatic cancer.

Authors:  Shanshan Liu; Qiuyue Li; Yan Ma; Christopher Corpe; Jin Wang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

Review 9.  Effect of exosomal miRNA on cancer biology and clinical applications.

Authors:  Zhenqiang Sun; Ke Shi; Shuaixi Yang; Jinbo Liu; Quanbo Zhou; Guixian Wang; Junmin Song; Zhen Li; Zhiyong Zhang; Weitang Yuan
Journal:  Mol Cancer       Date:  2018-10-11       Impact factor: 27.401

10.  A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.

Authors:  Meng Zhuo; Cuncun Yuan; Ting Han; Jiujie Cui; Feng Jiao; Liwei Wang
Journal:  BMC Cancer       Date:  2018-10-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.